Since P53 signaling pathway plays a central role in the pathogenesis of Phf6 KO + JAK3M511I T-ALL, we sought to determine whether dual activation of P53 and inactivation of JAK3 would be beneficial in Phf6 KO + JAK3M511I T-ALL mice. The gene discussed is JAK3; the disease is acute lymphoblastic leukemia.